Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Clinical Oncology 1, 62 (1 December 2004) | doi:10.1038/ncponc0038
Single-agent cyclophosphamide in hepatoblastoma
Abstract
Cacciavillano WD et al. (2004) Phase II study of high-dose cyclophosphamide in relapsing and/or resistant hepatoblastoma in children: a study from the SIOPEL group. Eur J Cancer 40: 2274–2279 There is currently no consensus regarding the treatment of children with resistant or relapsing hepatoblastoma.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
